[Malaria--chemoprophylaxis 2001].Ther Umsch. 2001 Jun; 58(6):347-51.TU
Abstract
An estimated 20,000 to 30,000 cases of imported malaria are annually diagnosed in industrialised countries. Some 700 of them concern Swiss travellers and foreign guests. Exposure prophylaxis and chemoprophylaxis for high risk destinations lower the risk of malarial disease. The latter is defined as regular intake of antimalarial drugs in subtherapeutic dosage in order to suppress the development of clinical disease. Drugs are usually taken from one week before travel until four weeks after return from an endemic area. Mefloquine, doxycycline, chloroquine plus proguanil, and presumably soon also atovaquone plus proguanil are available in Switzerland for chemoprophylaxis.
Links
MeSH
Pub Type(s)
Journal Article
Review
Language
ger
PubMed ID
11441694
Citation
Hatz, F R., et al. "[Malaria--chemoprophylaxis 2001]." Therapeutische Umschau. Revue Therapeutique, vol. 58, no. 6, 2001, pp. 347-51.
Hatz FR, Beck B, Blum J, et al. [Malaria--chemoprophylaxis 2001]. Ther Umsch. 2001;58(6):347-51.
Hatz, F. R., Beck, B., Blum, J., Funk, M., Furrer, H., Genton, B., Holzer, B., Loutan, L., Markwalder, K., Raeber, P. A., Schlagenhauf, P., Siegl, G., Steffen, R., Stürchler, D., & Wyss, R. (2001). [Malaria--chemoprophylaxis 2001]. Therapeutische Umschau. Revue Therapeutique, 58(6), 347-51.
Hatz FR, et al. [Malaria--chemoprophylaxis 2001]. Ther Umsch. 2001;58(6):347-51. PubMed PMID: 11441694.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [Malaria--chemoprophylaxis 2001].
AU - Hatz,F R,
AU - Beck,B,
AU - Blum,J,
AU - Funk,M,
AU - Furrer,H,
AU - Genton,B,
AU - Holzer,B,
AU - Loutan,L,
AU - Markwalder,K,
AU - Raeber,P A,
AU - Schlagenhauf,P,
AU - Siegl,G,
AU - Steffen,R,
AU - Stürchler,D,
AU - Wyss,R,
PY - 2001/7/10/pubmed
PY - 2001/8/31/medline
PY - 2001/7/10/entrez
SP - 347
EP - 51
JF - Therapeutische Umschau. Revue therapeutique
JO - Ther Umsch
VL - 58
IS - 6
N2 - An estimated 20,000 to 30,000 cases of imported malaria are annually diagnosed in industrialised countries. Some 700 of them concern Swiss travellers and foreign guests. Exposure prophylaxis and chemoprophylaxis for high risk destinations lower the risk of malarial disease. The latter is defined as regular intake of antimalarial drugs in subtherapeutic dosage in order to suppress the development of clinical disease. Drugs are usually taken from one week before travel until four weeks after return from an endemic area. Mefloquine, doxycycline, chloroquine plus proguanil, and presumably soon also atovaquone plus proguanil are available in Switzerland for chemoprophylaxis.
SN - 0040-5930
UR - https://www.unboundmedicine.com/medline/citation/11441694/[Malaria__chemoprophylaxis_2001]_
L2 - https://econtent.hogrefe.com/doi/10.1024/0040-5930.58.6.347?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed
DB - PRIME
DP - Unbound Medicine
ER -